The Assessment for Disinvestment of Intramuscular Interferon Beta for Relapsing-Remitting Multiple Sclerosis in Brazil – home – RedETSA

The Assessment for Disinvestment of Intramuscular Interferon Beta for Relapsing-Remitting Multiple Sclerosis in Brazil – home

Publicação conjunta da UFMG e o Instituto Nacional de Cardiologia para suporte à decisão da CONITEC, incluiu estudo de comparação indireta e dados de vida real sobre falha no tratamento.
The Assessment for Disinvestment of Intramuscular Interferon Beta for Relapsing-Remitting Multiple Sclerosis in Brazil – home